Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Futura Medical Plc (OP:FAMDF)

0.0200 UNCHANGED
Last Price Updated: 9:32 AM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Futura Medical Plc

News headline image
Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024
Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024 
Via News Direct
Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder tells Proactive's Stephen Gunnion about a strategic shift and refresh for the company in 2023, marked by the successful launch of Eroxon in the... 
Via TheNewswire.com
Futura Medical continues global expansion with Latin America announcement
--News Direct-- 
Via News Direct
Futura Medical continues global expansion with Latin America announcement
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive London after the pharmaceutical company announced another milestone in its global expansion efforts. 
Via TheNewswire.com
Futura Medical "on track for a profit in 2025" after strong first half
--News Direct-- 
Via News Direct
Futura Medical "on track for a profit in 2025" after strong first half
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive London after the pharmaceutical company announced its interim results for the six months to 30 June... 
Via TheNewswire.com
News headline image
Futura Medical "absolutely delighted" with US commercialisation agreement
Futura Medical "absolutely delighted" with US commercialisation agreement 
Via News Direct
Futura Medical "absolutely delighted" with US commercialisation agreement
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive London after announcing the signing of an agreement with Haleon to market Futura's topical, gel-based... 
Via TheNewswire.com
News headline image
Futura Medical debuts Eroxon in UK and says "more launches coming"
Futura Medical debuts Eroxon in UK and says "more launches coming" 
Via News Direct
Futura Medical debuts Eroxon in UK and says "more launches coming"
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive after launching innovative erectile dysfunction (ED) treatment gel Eroxon in the UK market. 
Via TheNewswire.com
News headline image
Futura Medical "confident of getting FDA approval this quarter"
Futura Medical "confident of getting FDA approval this quarter" 
Via News Direct
Futura Medical "confident of getting FDA approval this quarter"
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive following the release of full year results for 2022. 
Via TheNewswire.com
News headline image
Futura Medical expects FDA approval for topical ED treatment during Q2
Futura Medical expects FDA approval for topical ED treatment during Q2 
Via News Direct
Futura Medical expects FDA approval for topical ED treatment during Q2
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive's Thomas Warner after announcing the European online launch of topical erectile dysfunction (ED) treatment MED3000, under... 
Via TheNewswire.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback